-
Ferring Statement on Minirin® / Octostim® / DDAVP® / Stimate® (desmopressin) Nasal Spray
in STATEMENT 2022 onFollowing the detection of out-of-specification results during testing, in 2020 Ferring initiated a precautionary voluntary global recall of all batches of the following products: Minirin® (desmopressin) Nasal Spray 0.1 mg/ml…
-
Ferring statement on the Ukraine crisis
in STATEMENT 2022 onAs we witness the escalating humanitarian crisis caused by the war in Ukraine, Ferring continues to stand by the people impacted and support those in need. As a healthcare company with a purpose to build families and help people live better lives, we are supporting three major emergency relief efforts…
STATEMENT 2022
STATEMENT 2022